Msh Capital Advisors LLC Amgen Inc Transaction History

Msh Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$258.78 - $328.31 $1.37 Million - $1.74 Million	-5,304 Closed	0 $0
Q4 2022 Feb 13, 2025	SELL	$229.03 - $291.01 $1.22 Million - $1.55 Million	-5,329 Closed	0 $0
Q3 2022 Feb 13, 2025	BUY	$224.46 - $253.15 $1.2 Million - $1.35 Million	5,329 New	5,329 $1.2 Billion
Q2 2022 Feb 13, 2025	SELL	$230.71 - $256.74 $23,532 - $26,187	-102 Reduced 1.89%	5,304 $1.29 Billion
Q1 2022 Feb 13, 2025	BUY	$219.27 - $242.57 $46,046 - $50,939	210 Added 4.04%	5,406 $1.31 Billion
Q4 2021 Feb 13, 2025	BUY	$198.88 - $227.6 $1.03 Million - $1.18 Million	5,196 New	5,196 $1.17 Billion

3,144

415M

8.2M

6.65M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Msh Capital Advisors LLC with notifications on news.